According to the NCCN Guidelines for metastatic lung cancer, standard therapies remain valuable, but they are no longer sufficient on their own. This is why molecular profiling, targeted therapy, and ...

Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "Cyberknife Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The CyberKnife market is redefining precision ...

Despite SBRT to oligometastatic sites, prostate cancer progression still occurs in a majority of patients due to occult microscopic disease.

SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...

Last month, IceCure Medical’s tumor-freezing technology won FDA approval for treating early-stage breast cancer. Now, the Israel-based medtech is touting a new study showing its procedure combined ...

Some anxiety is part of the cost of admission to humanity. Because its distinguishing raison d’etre is the anticipation of bad outcomes, it can be a helpful stimulus to preparation or rehearsal before ...

If you have acne-prone skin, you're probably familiar with those pesky dark spots on the forehead, nose or chin, commonly known as blackheads. Although it may be tempting to pop and pick at them when ...

Former President Joe Biden finished a weekslong course of radiation therapy Monday for Stage 4 prostate cancer that has spread to his bones. Biden, 82, celebrated the milestone at Penn Medicine ...